Prescient Therapeutics Limited (ASX:PTX)

Prescient Therapeutics Ratios and Metrics

Market cap in millions AUD. Fiscal year is July - June.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 30, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Market Capitalization	55	35	31	65	101	157
Market Cap Growth	65.60%	15.79%	-53.08%	-35.69%	-35.43%	637.70%
Enterprise Value	45	27	12	44	87	139
Last Close Price	0.05	0.04	0.04	0.08	0.15	0.24
PS Ratio	12.82	8.13	8.24	26.86	53.68	132.49
PB Ratio	3.22	3.11	1.69	2.50	6.05	7.69
P/TBV Ratio	3.57	3.64	1.86	2.87	7.57	9.21
EV/Sales Ratio	10.59	6.21	3.28	18.23	45.86	116.91
Debt / Equity Ratio	0.02	-	0.02	-	-	0.01
Net Debt / Equity Ratio	-0.56	-0.61	-0.78	-0.84	-0.73	-0.78
Net Debt / EBITDA Ratio	-	0.92	1.97	2.94	2.36	3.76
Net Debt / FCF Ratio	1.19	0.96	1.92	3.54	2.85	4.02
Asset Turnover	0.24	0.25	0.15	0.11	0.10	0.07
Quick Ratio	12.10	3.75	7.95	12.09	17.31	33.72
Current Ratio	12.95	4.08	8.08	12.21	17.61	34.19
Return on Equity (ROE)	-54.33%	-49.72%	-37.32%	-32.70%	-27.52%	-26.25%
Return on Assets (ROA)	-31.75%	-26.95%	-18.52%	-20.39%	-16.88%	-16.05%
Return on Capital Employed (ROCE)	-51.80%	-66.10%	-39.80%	-28.60%	-31.00%	-20.70%
Earnings Yield	-16.20%	-20.66%	-26.92%	-10.74%	-5.05%	-2.64%
FCF Yield	-	-20.44%	-24.17%	-9.49%	-4.26%	-2.53%
Buyback Yield / Dilution	-12.27%	-	-10.69%	-12.31%	-5.88%	-55.18%

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.